2009-02-05 10:20 Results of the ALLAY study, published in Circulation, shows that Aliskiren is as effective as Losartan in reducing LV mass. The follow-up (after 36 weeks) also showed that Aliskiren proved equally effective in lowering blood pressure. Aliskiren is the first orally active direct renin inhibitor.
Tag: scandinavia
Pressmeddelanden
Nyheter
2010-02-20 11:29 The Lancet, published february 18, contained an article with further findings from the ACCOMPLISH trial.
2010-01-14 10:49 A+ Science has moved into new premises in Lund. If you're in the area, give us a call and drop by - we'd love to show you where we are and talk about new business opportunities!
2009-12-14 14:30 Biotech Sweden, one of the Nordic countries most read news media, elects an editorial council. The council aims to act as advisors and gather information about everything that affects the life science industry. Among the elected is A+ Science CEO, Agneta Franksson.